SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

WEEDCOIN is trending amidst community discussions surrounding the potential rescheduling of cannabis and upcoming policy deadlines for hemp products, with enthusiasts highlighting its role as a culture-first cryptocurrency on Solana ahead of the 4/20 period. The narrative emphasizes its alignment with the broader cannabis movement and a long-term, patient investment approach.

iShares Trust - iShares 0-3 Month Treasury Bond ETF

iShares 0-3 Month Treasury Bond ETF

Investors are increasingly turning to SGOV, the iShares 0-3 Month Treasury Bond ETF, as a secure 'cash parking' strategy amid broader market uncertainty and anticipation of a potential pullback. The community is actively touting its attractive 4-5% monthly yield and state tax exemption as a preferred low-risk alternative to traditional savings accounts and higher-volatility assets.

SSgA Active Trust - State Street Materials Select Sector SPDR ETF

Materials Select Sector SPDR Fund

Materials Select Sector SPDR Fund (XLB) is gaining significant attention following recent tariff announcements on key minerals like copper and Chinese graphite, which are seen as inflationary catalysts boosting domestic production. The community is actively discussing a broader market rotation into materials as an undervalued cyclical sector and inflation hedge, with many anticipating further upside despite some calls for consolidation.

SSgA Active Trust - State Street Industrial Select Sector SPDR ETF

Industrial Select Sector SPDR Fund

The Industrial Select Sector SPDR Fund (XLI) is trending as the community highlights its strong technical structure and leadership amid broader market rotation, fueled by impressive industrial earnings and a positive outlook for manufacturing activity.

SSgA Active Trust - State Street Technology Select Sector SPDR ETF

Technology Select Sector SPDR Fund

XLK is drawing investor attention amid a noticeable sector rotation away from technology and into areas like energy and defensive stocks. This shift is amplified by varied earnings reports from major tech components and ongoing concerns within the community about the sustainability of AI-driven growth and high capital expenditures.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins is drawing significant community discussion propelled by high-visibility marketing on the Las Vegas Sphere and new partnerships with brands like the NHL, fueling anticipation for its expanding real-world utility amid fluctuating meme coin sentiment.

SSgA Active Trust - State Street Utilities Select Sector SPDR ETF

Utilities Select Sector SPDR Fund

The Utilities Select Sector SPDR Fund (XLU) is trending as a dual play, offering investors a defensive haven amid market uncertainty while also being a direct beneficiary of surging electricity demand from AI data centers. This dynamic is driving its strong price momentum, prompting community discussion on whether the sector's current valuation is sustainable or becoming overextended.

Alimentation-Couche Tard, Inc.

Alimentation Couche-Tard is trending as community sentiment shifts from prolonged frustration to renewed optimism following the withdrawal of its major acquisition bid. Many now view the removal of this potential overhang as a catalyst for the convenience store giant to finally "awaken" and break out beyond stagnant trading ranges.

Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. The firm's lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner in 2017 and is headquartered in Dallas, TX.

Forte Biosciences Inc

Forte Biosciences is trending following an oversubscribed $53 million private placement from leading healthcare institutional investors, coupled with promising Phase 1b trial data for its FB102 candidate in celiac disease. The community is actively debating the stock's potential for a significant rally due to the low float and strong institutional backing, amidst discussions of past volatility and potential dilution.

Rapid7, Inc. engages in the provision of cyber security analytics and automation services. Its products include Metasploit, Nexpose, AppSpider, tCell by Rapid7, as well as insight platforms such as InsightDR, InsightIVM, InsightAppSec, InsightConnect, and InsightOps. The firm also offers security and product consulting services. The company was founded by Alan P. Matthews, Tas Giakouminakis, and Chad Loder in July 2000 and is headquartered in Boston, MA.

Rapid7 Inc

A recent sharp stock decline, driven by analyst downgrades and cautious forward guidance, has Rapid7 Inc. trending as investors debate its valuation. The community is actively discussing the potential for a private equity buyout, spurred by activist investor interest and high institutional ownership, viewing it as a deep value play in the consolidating cybersecurity sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Mangoceuticals believes the current crypto market offers a strategic opportunity to capitalize on current price levels.</li><li>The company has appointed Cube Group as the asset manager for its DAT.</li><li>As part of the MULTI-DAT framework, the company is pursuing a range of strategic digital asset and DeFi initiatives to enhance its treasury operations further.</li></ul>Health and wellness company Mangoceuticals <a href="https://stocktwits.com/symbol/MGRX">(MGRX</a>) on Friday announced that it is launching a Solana-focused digital asset treasury (DAT) of up to $100 million through its newly formed subsidiary, Mango DAT, in partnership with Cube Group.Cube Group has been appointed as the asset manager responsible for custody and execution.<h2 class="st-heading-2">Strategic Opportunity</h2>Mangoceuticals believes that the current crypto market offers a strategic opportunity to capitalize on current prices, enabling optimized entry points for long-term value creation. "We are optimistic about Solana’s future and confident this strategy will provide compelling, non-dilutive returns while positioning Mangoceuticals as a leader at the intersection of traditional finance and blockchain technology," said Jacob Cohen, Founder and CEO of Mangoceuticals.Solana’s&nbsp;<a href="https://stocktwits.com/coins/solana">price</a> was trading 1.7% higher at around $125.47 at the time of writing. Meanwhile, Mangoceuticals shares slumped nearly 47% on Friday. Retail sentiment around Mangoceuticals on Stocktwits trended in “extremely bullish” amid “extremely high” message volume.&nbsp;<figure class="image"><img style="aspect-ratio:633/73;" src="https://news.stocktwits-cdn.com/MGRX_PNG_9360d011fb.webp" alt="Retail sentiment around Mangoceuticals on Stocktwits trended in “extremely bullish” amid “extremely high” message volume. " width="633" height="73"></figure><h2 class="st-heading-2">MULTI-DAT Framework</h2>Mangoceuticals has recently filed a trademark&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://tsdr.uspto.gov/#caseNumber=99483190&amp;caseSearchType=US_APPLICATION&amp;caseType=DEFAULT&amp;searchType=statusSearch">application</a> for MULTI-DAT to the United States Patent and Trademark Office, signaling its strategic expansion into the digital asset sector.As part of the MULTI-DAT framework, the company is pursuing a range of strategic digital asset and DeFi initiatives to enhance its treasury operations further. This will allow the firm to conduct various financial operations, including facilitating virtual currency transactions and exchanges, processing electronic fund transfers, managing investment portfolios, and running blockchain-driven cryptocurrency services.&nbsp;By diversifying its activities, Mangoceuticals aims to mitigate the risks associated with market volatility, which often affects strategies that depend solely on token price movements.A Digital Asset Treasury is a type of firm that buys and holds cryptocurrencies on its balance sheet. One of the biggest DAT companies is Michael Saylor-backed Strategy (MSTR), which began buying bitcoin in 2020 and has been continuing to do so ever since. Notably, the number of DAT companies has expanded over the years.According to&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.dlapiper.com/en/insights/publications/2025/10/key-capital-market-trends-digital-asset-treasuries">DLA Piper</a>, as of September 2025, more than 200 companies had adopted DAT strategies, with more than 190 focused on BTC treasuries and another 10-20 on alternative digital assets.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Solana logo displayed on a phone screen and representation of cryptocurrencies are seen in this illustration photo taken in Krakow, Poland on August 21, 2021. (Photo Illustration by Jakub Porzycki/NurPhoto via Getty Images)

Mangoceuticals Announces Solana-Focused $100M Digital Asset Treasury, Sees ‘Compelling, Non-Dilutive Returns’

Mangoceuticals had also recently filed a trademark application for “MULTI-DAT” with the United States Patent and Trademark Office in a bid to expand into the digital asset space

Cryptocurrency

Mangoceuticals had also recently filed a trademark application for “MULTI-DAT” with the United States Patent and Trademark Office in a bid to expand into the digital asset space. 

Insider Selling: Mangoceuticals (NASDAQ:MGRX) CFO Sells 10,000 Shares of Stock

Mangoceuticals, Inc. (NASDAQ:MGRX - Get Free Report) CFO Eugene Johnston sold 10,000 shares of Mangoceuticals stock in a transaction that occurred on Friday, December 5th. The shares were sold at an...

Insider Selling: Mangoceuticals (NASDAQ:MGRX) Director Sells 125,000 Shares of Stock

Mangoceuticals, Inc. (NASDAQ:MGRX - Get Free Report) Director Alex Hamilton sold 125,000 shares of the stock in a transaction on Wednesday, November 19th. The shares were sold at an average price of...

<ul class="summary-bullets"><li>The obesity medications will be made available to both MangoRx and PeachesRx customers through Eli Lilly’s LillyDirect Self-Pay Pharmacy Solutions and Novo Nordisk’s NovoCare Pharmacy, Mangoceuticals said.</li><li>The drugs will be available for home delivery for as low as $499 per month, the company added.</li><li>A Novo Nordisk spokesperson noted in an emailed statement that the company “was not made aware of the announcement.”</li></ul>Shares of Mangoceuticals, Inc. (MGRX) jumped 23% in the pre-market session on Thursday after the telehealth company announced the launch of programs that provide direct access to authentic weight loss medicines from drugmakers Eli Lilly and Novo Nordisk.The company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://feeds.issuerdirect.com/news-release.html?newsid=5668113967057105&amp;symbol=MGRX">said</a> that it has launched two programs called MangoRx Direct and PeachesRx Direct to provide direct access to Lilly’s Zepbound and Novo’s Wegovy medicines.<h2 class="st-heading-2">How Will The Partnership Work?</h2>Customers can receive virtual consultations with providers on Mangoceuticals’ telehealth platform and get personalized obesity and weight management plans and also get their GLP-1 medicines delivered to them.The obesity medications will be made available to both MangoRx and PeachesRx customers through Eli Lilly’s LillyDirect Self-Pay Pharmacy Solutions and Novo Nordisk’s NovoCare Pharmacy. Both NovoCare and LillyDirect are aimed at providing medicines direct-to-consumer. While LillyDirect was launched last year, NovoCare was started earlier this year.The drugs will be available for home delivery for as low as $499 per month, the company said. Customers can also opt to pick up their prescriptions at a neighborhood pharmacy of their choice.“No insurance is required, making the programs ideal for self-pay, uninsured, underinsured and high-deductible patients,” Mangoceuticals CEO Jacob Cohen said.<h2 class="st-heading-2">Novo Nordisk’s Statement</h2>A Novo Nordisk spokesperson noted in an emailed statement that the company “was not made aware of the announcement issued this morning by Mangoceuticals. We do not have any agreement or partnership with this company.”<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/MGRX">MGRX stock</a> stayed within the ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘high’ to ‘extremely high’ levels.MGRX stock is down by 27% this year and by 28% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/mrsn-stock-soars-pre-market-after-day-one-acquisition-deal/cLP9RQdRE3Q">MRSN Stock Soars Over 200% Pre-Market After Day One Acquisition Deal</a>For updates and corrections, email newsroom[at]stocktwits[dot]comEditor's Note: The story has been updated with Novo Nordisk's emailed statement.

Rising stock market chart on a trading board background.

Why Did Mangoceuticals Shares Rise Today?

 The company has launched two programs, MangoRx Direct and PeachesRx Direct, to provide access to Lilly’s Zepbound and Novo’s Wegovy medicines.

Equity

 The company has launched two programs, MangoRx Direct and PeachesRx Direct, to provide access to Lilly’s Zepbound and Novo’s Wegovy medicines.


Mangoceuticals, Inc. engages in developing, marketing, and selling men's wellness products and services via a telemedicine platform. The company was founded on October 7, 2021 and is headquartered in Dallas, TX.

Mangoceuticals Inc

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

MGRX
Mangoceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest MGRX News

MGRXMangoceuticals Inc